Bio
Matthew Hung, M.D. is a radiologist specializing in Vascular & Interventional Radiology. Dr. Hung earned his M.D. from the David Geffen School of Medicine at UCLA in 2018 and was a recipient of the David Geffen Medical Scholarship. He completed his Transitional Year internship at Memorial Sloan Kettering Cancer Center in 2019. Following completion of his integrated Interventional Radiology/Diagnostic Radiology residency at the Hospital of the University of Pennsylvania in 2024, he joined Stanford University Medical Center as a clinical instructor in the Clinician Educator Line.
Dr. Hung specializes in interventional oncology (minimally invasive cancer treatments including ablation, chemoembolization and radioembolization), the treatment of cirrhosis (end-stage liver disease) and portal hypertension, as well as therapies for uterine fibroids (uterine artery embolization) and benign prostatic hyperplasia (prostate artery embolization).
Dr. Hung is active in clinical research and his research interests include the above clinical domains as well as topics in general interventional radiology ranging from complex drainage to venous access device infections. He has published in peer-reviewed journals such as the Journal of Vascular and Interventional Radiology (JVIR) and presented at several professional society meetings, including the Society of Interventional Radiology (SIR). He was also a recipient of the SIR Radiology Resident Research Grant, investigating quality of life and muscle wasting in patients with refractory ascites.
